Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adams, L. S.
Right arrow Articles by Teegarden, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adams, L. S.
Right arrow Articles by Teegarden, D.
© 2004 The American Society for Nutritional Sciences J. Nutr. 134:2948-2952, November 2004


Biochemical and Molecular Actions of Nutrients

1,25-Dihydroxycholecalciferol Inhibits Apoptosis in C3H10T1/2 Murine Fibroblast Cells Through Activation of Nuclear Factor {kappa}B1

Lynn S. Adams and Dorothy Teegarden2

Department of Foods and Nutrition, Purdue University, West, Lafayette, IN 47907

2To whom correspondence should be addressed. E-mail: Teegarden{at}cfs.purdue.edu.

1,25-dihydroxycholecalciferol [1,25(OH)2D3] is important in the regulation of cell growth, differentiation, and apoptosis. Previous results from our laboratory demonstrate that 1,25(OH)2D3 inhibits vitamin E succinate (VES) mediated apoptosis in untransformed C3H10T1/2 mouse fibroblast cells. The current work investigated cell survival signaling pathways that may be activated by 1,25(OH)2D3, leading to protection from apoptosis. Results showed that nuclear factor {kappa}B (NF{kappa}B) transcriptional activity was significantly increased 1.8-fold over vehicle controls by 1,25(OH)2D3 after 4 h of treatment. Protein kinase B/AKT, a downstream effector of phosphoinositide 3-kinase (PI3K), was activated 4-fold and 8-fold at 2 and 4 h, respectively, after treatment with 1,25(OH)2D3. Pretreatment with two PI3K inhibitors, LY294002 and wortmannin, abolished the activation of NF{kappa}B by 1,25(OH)2D3, suggesting that this pathway is essential for NF{kappa}B transcriptional activation. Additionally, the use of a p-21 activated kinase (PAK1) inhibitory construct (PAKR299) demonstrated that PAK1 was also required for NF{kappa}B transcriptional activation by 1,25(OH)2D3. Inhibition of NF{kappa}B activity with transfection of the NF{kappa}B inhibitory construct (I{kappa}BAla32) abolished the protective effect of 1,25(OH)2D3 on VES-mediated apoptosis. In summary, NF{kappa}B transcriptional activation was essential to 1,25(OH)2D3 protection from VES-mediated apoptosis and 1,25(OH)2D3 regulated NF{kappa}B activity through PI3K and PAK pathways.


KEY WORDS: • 1,25-dihydroxycholecalciferol • p21 activated kinase • nuclear factor {kappa}B • phosphoinositide-3-kinase • C3H10T1/2 cells




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. Sakurai, E. Shin, S. Fonseca, T. Sakurai, A. A. Litonjua, S. T. Weiss, J. S. Torday, and V. K. Rehan
1{alpha},25(OH)2D3 and its 3-epimer promote rat lung alveolar epithelial-mesenchymal interactions and inhibit lipofibroblast apoptosis
Am J Physiol Lung Cell Mol Physiol, September 1, 2009; 297(3): L496 - L505.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2004 by American Society for Nutrition